Jan Terje Andersen
Company: Oslo University | Oslo University Hospital
Job title: Professor in Biomedical Innovation | Research Group Leader | CoE Precision Immunotherapy Alliance (PRIMA)
Seminars:
8:30 am Biology-Guided Engineering of Antibody & Albumin Molecules 8:30 am
FcRn as a key homeostatic regulator of both IgG and albumin Why considering large cross-species FcRn binding differences Engineering of antibody and albumin formats with tailored binding and transport properties Modulating transplacental transport of antibody and albumin designsRead more
day: Conference Day Two
Strategies to Tailor the PK of Biologics, with or without Effector Functions 11:30 am
day: Day Two Roundtable - B